Pediatric allergist, Dr. BJ Lanser, at National Jewish Health, the hospital that helped run a clinical trial on a treatment for peanut allergy sufferers. He went on to say, This is a big deal, but with this caveat that this is not an easy, simple cure and the therapy isn”t going to be for everyone.

• first-ever peanut allergy treatment
• Patient receives doses orally.
• Initial patients: 4-17 years old.
• Works to de-sensitive patients to peanuts through giving them small doses.
• FDA Advisory Committee voted to approve the treatment – the FDA *normally* follows the committees recommendations for full approval to get the treatment to the U.S. market.

READ MORE:

FDA committee votes to approve peanut allergy treatment that had clinical trials at National JewishA Health